NEW YORK (GenomeWeb News) – Investigators at the Polytechnic Institute of New York University and NYU plan to use a $1.2 million grant from the National Institutes of Health to study how histones may be involved in cancer and diabetes, NYU-Poly said today.

The research team plans to use computational chemistry and protein engineering approaches to study these scaffolding proteins, which are modified by enzymes called histone acetyltransferases, or HATs. Those changes can then affect gene expression.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Decode Genetics' ability to tell Icelanders, even ones the company hasn't sequenced, about their disease risk brings up ethical questions.

Genetic analysis of Britain's King Richard III and modern descendants of his relatives indicate breaks in the male line.

In Nature this week: Icelandic genome sequences, approach to increase CRISPR efficiency, and more.

Testing showing "genetic incompatibilities" have led thousands of couples in Saudi Arabia to call off their weddings, the BBC reports.